PharmaCyte Biotech, Inc.
PMCB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001157075
No open-market purchases or sales by PharmaCyte Biotech, Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $586.2K in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in PharmaCyte Biotech, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- −2 vs. Q4 2021
- Shares held
- 3.84M
- +369.4K (+10.6%) vs. Q4 2021
- Total value
- $8.83M
- +$150.9K (+1.7%) vs. Q4 2021
- New holders
- 4
- 8 more added
- Sold out
- 6
- 4 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMCB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 32 | $586.2K |
| Q1 2026 | 36 | $643.2K |
| Q4 2025 | 30 | $712.0K |
| Q3 2025 | 25 | $419.9K |
| Q2 2025 | 25 | $632.1K |
| Q1 2025 | 26 | $709.9K |
| Q4 2024 | 23 | $934.3K |
| Q3 2024 | 29 | $1.58M |
| Q2 2024 | 32 | $2.02M |
| Q1 2024 | 33 | $2.32M |
| Q4 2023 | 36 | $2.35M |
| Q3 2023 | 34 | $2.40M |
| Q2 2023 | 32 | $3.47M |
| Q1 2023 | 33 | $10.2M |
| Q4 2022 | 34 | $9.93M |
| Q3 2022 | 33 | $12.0M |
| Q2 2022 | 35 | $8.79M |
| Q1 2022 | 28 | $8.83M |
| Q4 2021 | 30 | $8.68M |
| Q3 2021 | 24 | $4.42M |
| Q2 2021 | 5 | $5.43K |
| Q1 2021 | 5 | $8.68K |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding PharmaCyte Biotech, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 213 | $0 | 0.00% | −1,550−87.9% | Reduced |
| Huntington National Bank | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 58 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 128 | $0 | 0.00% | +1+0.8% | Added |
| Royal Bank of Canada | 98 | $0 | 0.00% | 00.0% | Unchanged |
| Blue Bell Private Wealth Management, LLC | 2 | $0 | 0.00% | 00.0% | Unchanged |
| TCI Wealth Advisors, Inc. | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Carolina Wealth Advisors, LLC | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 7 | $16 | 0.00% | 00.0% | Unchanged |
| Anchor Investment Management, LLC | 27 | $62 | 0.00% | 00.0% | Unchanged |
| Kelly Financial Services LLC | 262 | $603 | 0.00% | 00.0% | Unchanged |
| Aspire Private Capital, LLC | 800 | $2.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2,723 | $6.00K | 0.00% | +2,723 | New |
| UBS Group AG | 5,832 | $13.0K | 0.00% | +2,171+59.3% | Added |
| Schonfeld Strategic Advisors LLC | 26,300 | $60.0K | 0.00% | −4,100−13.5% | Reduced |
| Susquehanna International Group, LLP | 28,062 | $65.0K | 0.00% | +28,062 | New |
| Susquehanna Fundamental Investments, LLC | 34,805 | $80.0K | 0.00% | −10,139−22.6% | Reduced |
| Northern Trust Corp | 35,641 | $82.0K | 0.00% | +185+0.5% | Added |
| State Street Corp | 37,600 | $86.0K | 0.00% | +37,600 | New |
| FNY Investment Advisers, LLC | 59,066 | $135.0K | 0.13% | +59,066 | New |
| Morgan Stanley | 61,869 | $142.0K | 0.00% | −6,264−9.2% | Reduced |
| Price T Rowe Associates Inc | 78,100 | $180.0K | 0.00% | 00.0% | Unchanged |
| Ayrton Capital LLC | 153,130 | $352.0K | 0.46% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 171,523 | $394.0K | 0.00% | +87,948+105.2% | Added |
| Equitec Proprietary Markets, LLC | 309,294 | $711.0K | 0.35% | +50,600+19.6% | Added |
| Vanguard Group Inc | 614,625 | $1.41M | 0.00% | +959+0.2% | Added |
| Shay Capital LLC | 944,666 | $2.17M | 0.78% | +282,329+42.6% | Added |
| Sabby Management, LLC | 1,275,468 | $2.93M | 1.26% | +57,640+4.7% | Added |
| Anson Funds Management LP | 0 | $0 | 0.00% | −193,400−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −13,515−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −10,300−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −650−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Comprehensive Financial Consultants Institutional, Inc. | 0 | $0 | 0.00% | −14−100.0% | Sold out |